1. Home
  2. NAZ vs TNYA Comparison

NAZ vs TNYA Comparison

Compare NAZ & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Arizona Quality Municipal Income Fund

NAZ

Nuveen Arizona Quality Municipal Income Fund

HOLD

Current Price

$11.96

Market Cap

162.0M

Sector

Finance

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.68

Market Cap

168.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAZ
TNYA
Founded
1992
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.0M
168.2M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
NAZ
TNYA
Price
$11.96
$0.68
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.33
AVG Volume (30 Days)
14.1K
1.8M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
3.69%
N/A
EPS Growth
N/A
54.96
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.63
$0.53
52 Week High
$13.42
$2.35

Technical Indicators

Market Signals
Indicator
NAZ
TNYA
Relative Strength Index (RSI) 33.48 44.84
Support Level $11.98 $0.66
Resistance Level $12.11 $0.82
Average True Range (ATR) 0.13 0.03
MACD -0.02 0.00
Stochastic Oscillator 9.52 61.04

Price Performance

Historical Comparison
NAZ
TNYA

About NAZ Nuveen Arizona Quality Municipal Income Fund

Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: